약물전달 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Drug Delivery Systems Market - Scope of Report

TMR's report on the global drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug delivery systems market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug delivery systems market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug delivery systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug delivery systems market.

The report delves into the competitive landscape of the global drug delivery systems market. Key players operating in the global drug delivery systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug delivery systems market profiled in this report.

Key Questions Answered in global drug delivery systems Market Report:

• What is the sales/revenue generated by drug delivery systems across all regions during the forecast period?
• What are the opportunities in the global drug delivery systems market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Drug Delivery Systems Market - Research Objectives and Research Approach

The comprehensive report on the global drug delivery systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug delivery systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug delivery systems market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Delivery Systems Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Drug Delivery Systems Market Analysis and Forecasts, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. Technological Advancements in Drug Delivery Systems
• 5.3. Regulatory Scenario across Key Regions / Countries
• 5.4. PORTER's Five Forces Analysis
• 5.5. PESTLE Analysis
• 5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Drug Delivery Systems Market Analysis and Forecasts, By Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Type, 2020-2035
  • 6.3.1. Oral Drug Delivery System
    • 6.3.1.1. Controlled-release Drug Delivery
    • 6.3.1.2. Other Oral Drug Delivery
  • 6.3.2. Injection-based Drug Delivery System
    • 6.3.2.1. Injectable Drug Delivery System
    • 6.3.2.2. Injectable Devices
  • 6.3.3. Transdermal Drug Delivery System
  • 6.3.4. Inhalation Drug Delivery System
  • 6.3.5. Implantable Drug Delivery System
  • 6.3.6. Others
• 6.4. Market Attractiveness By Type

7. Global Drug Delivery Systems Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020-2035
  • 7.3.1. Oncological Disorders
  • 7.3.2. Infectious Diseases
  • 7.3.3. Respiratory Disorders
  • 7.3.4. Cardiovascular Disorders
  • 7.3.5. Autoimmune Disorders
  • 7.3.6. CNS Disorders
  • 7.3.7. Others
• 7.4. Market Attractiveness By Application

8. Global Drug Delivery Systems Market Analysis and Forecasts, By End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By End-user, 2020-2035
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Surgical Centers
  • 8.3.3. Homecare Settings
  • 8.3.4. Others
• 8.4. Market Attractiveness By End-user

9. Global Drug Delivery Systems Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Region

10. North America Drug Delivery Systems Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Type, 2020-2035
  • 10.2.1. Oral Drug Delivery System
    • 10.2.1.1. Controlled-release Drug Delivery
    • 10.2.1.2. Other Oral Drug Delivery
  • 10.2.2. Injection-based Drug Delivery System
    • 10.2.2.1. Injectable Drug Delivery System
    • 10.2.2.2. Injectable Devices
  • 10.2.3. Transdermal Drug Delivery System
  • 10.2.4. Inhalation Drug Delivery System
  • 10.2.5. Implantable Drug Delivery System
  • 10.2.6. Others
• 10.3. Market Value Forecast By Application, 2020-2035
  • 10.3.1. Oncological Disorders
  • 10.3.2. Infectious Diseases
  • 10.3.3. Respiratory Disorders
  • 10.3.4. Cardiovascular Disorders
  • 10.3.5. Autoimmune Disorders
  • 10.3.6. CNS Disorders
  • 10.3.7. Others
• 10.4. Market Value Forecast By End-user, 2020-2035
  • 10.4.1. Hospitals
  • 10.4.2. Ambulatory Surgical Centers
  • 10.4.3. Homecare Settings
  • 10.4.4. Others
• 10.5. Market Value Forecast By Country, 2020-2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Type
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Drug Delivery Systems Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Type, 2020-2035
  • 11.2.1. Oral Drug Delivery System
    • 11.2.1.1. Controlled-release Drug Delivery
    • 11.2.1.2. Other Oral Drug Delivery
  • 11.2.2. Injection-based Drug Delivery System
    • 11.2.2.1. Injectable Drug Delivery System
    • 11.2.2.2. Injectable Devices
  • 11.2.3. Transdermal Drug Delivery System
  • 11.2.4. Inhalation Drug Delivery System
  • 11.2.5. Implantable Drug Delivery System
  • 11.2.6. Others
• 11.3. Market Value Forecast By Application, 2020-2035
  • 11.3.1. Oncological Disorders
  • 11.3.2. Infectious Diseases
  • 11.3.3. Respiratory Disorders
  • 11.3.4. Cardiovascular Disorders
  • 11.3.5. Autoimmune Disorders
  • 11.3.6. CNS Disorders
  • 11.3.7. Others
• 11.4. Market Value Forecast By End-user, 2020-2035
  • 11.4.1. Hospitals
  • 11.4.2. Ambulatory Surgical Centers
  • 11.4.3. Homecare Settings
  • 11.4.4. Others
• 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Type
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country / Sub-region

12. Asia Pacific Drug Delivery Systems Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Type, 2020-2035
  • 12.2.1. Oral Drug Delivery System
    • 12.2.1.1. Controlled-release Drug Delivery
    • 12.2.1.2. Other Oral Drug Delivery
  • 12.2.2. Injection-based Drug Delivery System
    • 12.2.2.1. Injectable Drug Delivery System
    • 12.2.2.2. Injectable Devices
  • 12.2.3. Transdermal Drug Delivery System
  • 12.2.4. Inhalation Drug Delivery System
  • 12.2.5. Implantable Drug Delivery System
  • 12.2.6. Others
• 12.3. Market Value Forecast By Application, 2020-2035
  • 12.3.1. Oncological Disorders
  • 12.3.2. Infectious Diseases
  • 12.3.3. Respiratory Disorders
  • 12.3.4. Cardiovascular Disorders
  • 12.3.5. Autoimmune Disorders
  • 12.3.6. CNS Disorders
  • 12.3.7. Others
• 12.4. Market Value Forecast By End-user, 2020-2035
  • 12.4.1. Hospitals
  • 12.4.2. Ambulatory Surgical Centers
  • 12.4.3. Homecare Settings
  • 12.4.4. Others
• 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Type
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country / Sub-region

13. Latin America Drug Delivery Systems Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Type, 2020-2035
  • 13.2.1. Oral Drug Delivery System
    • 13.2.1.1. Controlled-release Drug Delivery
    • 13.2.1.2. Other Oral Drug Delivery
  • 13.2.2. Injection-based Drug Delivery System
    • 13.2.2.1. Injectable Drug Delivery System
    • 13.2.2.2. Injectable Devices
  • 13.2.3. Transdermal Drug Delivery System
  • 13.2.4. Inhalation Drug Delivery System
  • 13.2.5. Implantable Drug Delivery System
  • 13.2.6. Others
• 13.3. Market Value Forecast By Application, 2020-2035
  • 13.3.1. Oncological Disorders
  • 13.3.2. Infectious Diseases
  • 13.3.3. Respiratory Disorders
  • 13.3.4. Cardiovascular Disorders
  • 13.3.5. Autoimmune Disorders
  • 13.3.6. CNS Disorders
  • 13.3.7. Others
• 13.4. Market Value Forecast By End-user, 2020-2035
  • 13.4.1. Hospitals
  • 13.4.2. Ambulatory Surgical Centers
  • 13.4.3. Homecare Settings
  • 13.4.4. Others
• 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Type
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country / Sub-region

14. Middle East & Africa Drug Delivery Systems Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Type, 2020-2035
  • 14.2.1. Oral Drug Delivery System
    • 14.2.1.1. Controlled-release Drug Delivery
    • 14.2.1.2. Other Oral Drug Delivery
  • 14.2.2. Injection-based Drug Delivery System
    • 14.2.2.1. Injectable Drug Delivery System
    • 14.2.2.2. Injectable Devices
  • 14.2.3. Transdermal Drug Delivery System
  • 14.2.4. Inhalation Drug Delivery System
  • 14.2.5. Implantable Drug Delivery System
  • 14.2.6. Others
• 14.3. Market Value Forecast By Application, 2020-2035
  • 14.3.1. Oncological Disorders
  • 14.3.2. Infectious Diseases
  • 14.3.3. Respiratory Disorders
  • 14.3.4. Cardiovascular Disorders
  • 14.3.5. Autoimmune Disorders
  • 14.3.6. CNS Disorders
  • 14.3.7. Others
• 14.4. Market Value Forecast By End-user, 2020-2035
  • 14.4.1. Hospitals
  • 14.4.2. Ambulatory Surgical Centers
  • 14.4.3. Homecare Settings
  • 14.4.4. Others
• 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Type
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country / Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Company Market Share Analysis (2024)
• 15.3. Company Profiles
  • 15.3.1. Becton, Dickinson and Company
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. B. Braun Melsungen AG
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. Terumo Medical Corporation
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. Medtronic plc
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Koninklijke Philips N.V.
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Baxter International Inc.
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Pfizer Inc.
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Teva Pharmaceutical Industries Ltd.
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. Teleflex Incorporated
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. Novartis AG
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. Gerresheimer AG
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. Abbott
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. Ypsomed AG
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments
  • 15.3.14. SHL Medical
    • 15.3.14.1. Company Overview
    • 15.3.14.2. Financial Overview
    • 15.3.14.3. Product Portfolio
    • 15.3.14.4. Business Strategies
    • 15.3.14.5. Recent Developments
  • 15.3.15. Owen Mumford
    • 15.3.15.1. Company Overview
    • 15.3.15.2. Financial Overview
    • 15.3.15.3. Product Portfolio
    • 15.3.15.4. Business Strategies
    • 15.3.15.5. Recent Developments